Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kelvin Luu

Sports Medicine Columbus, OH Medical Doctor

NPI 1659725018 CMS profile 5700955

4604 Sawmill Rd, Columbus, OH 43220

Open in the dashboard

General payments

$22,012

56 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kelvin Luu of Columbus, OH is reported in the CMS Open Payments database as having received $22,012 across 56 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 70th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $743 9
2024 General $304 8
2023 General $90 4
2022 General $14,299 29
2021 General $3,701 4
2020 General $1,076 1
2019 General $1,800 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kelvin Luu
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Kelvin Luu were reported at $743. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Kelvin Luu Sports Medicine median Middle half National median
2019 $1,800 $1,176 $199–$4,249 $163
2020 $1,076 $708 $96–$2,890 $114
2021 $3,701 $1,213 $152–$3,994 $132
2022 $14,299 $1,230 $159–$3,998 $149
2023 $90 $584 $146–$2,836 $160
2024 $304 $628 $163–$3,168 $164
2025 $743 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. SouthTech Orthopedics $6,000 5 payments
  2. CDC Medical LLC $5,529 7 payments
  3. Medical Device Business Services, Inc. $3,610 9 payments
  4. Arthrex, Inc. $3,600 3 payments
  5. Tricoast Surgical Solutions LLC $1,215 2 payments
  6. Stryker Corporation $1,081 8 payments
  7. Zimmer Biomet Holdings, Inc. $299 7 payments
  8. DePuy Synthes Sales Inc. $161 5 payments
  9. Smith+Nephew, Inc. $152 3 payments
  10. Exactech, Inc. $101 1 payment
  11. Other $264 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $16,097 14 payments
  2. Travel and Lodging $3,442 4 payments
  3. Food and Beverage $2,473 38 payments
Products named General payments · program years 2019–2025
  1. AIR $319 2 payments
  2. CINCHLOCK $273 2 payments
  3. ICONIX $160 1 payment
  4. SHARPSHOOTER $159 1 payment
  5. AEQUALIS PERFORM $155 1 payment
  6. Gel-One Cross-linked Hyaluronate $152 6 payments
  7. mymobility Platform $147 1 payment
  8. AEQUALIS PERFORM REVERSED $141 1 payment
  9. TORNIER PERFORM REVERSED GLENOID $141 1 payment
  10. AEQUALIS FLEX REVIVE $141 1 payment
  11. Other $961 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

575

Median for Orthopedic Surgery: 203

Drug cost

$2,680

Median for Orthopedic Surgery: $1,433

Branded share of claims

10.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 108 $690
Oxycodone Hcl Generic 108 $593
Naproxen Generic 122 $512
Ondansetron Odt Ondansetron Brand 42 $316
Meloxicam Generic 104 $280
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 17 $132
Prednisone Generic 37 $112
Cyclobenzaprine Hcl Generic 14 $29
Amoxicillin Generic 23 $17

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 94 billing codes

Paid by Medicare

$101,207

Of which drugs: $14,695

Medicare patients

237

Average age 75

Services billed

2,447

155 women, 82 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 71%
Depression 32%
Diabetes 30%
Chronic kidney disease 29%
Osteoporosis 24%
Ischemic heart disease 22%
Atrial fibrillation 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose J7326 Office 12 17 $7,019
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg J7325 Office 12 864 $5,982
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 73 496 $365

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

56 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record